Qube Research & Technologies LTD Aurinia Pharmaceuticals Inc. Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,242,512 shares of AUPH stock, worth $14.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,242,512
Previous 856,148
45.13%
Holding current value
$14.1 Million
Previous $6.88 Million
52.9%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding AUPH
# of Institutions
243Shares Held
62.3MCall Options Held
1.03MPut Options Held
665K-
Tang Capital Management LLC San Diego, CA10MShares$114 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$105 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$44.9 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$31.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$27.1 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.61B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...